MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Hygroscopic protect from moisture and light. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Abilify 10mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Zyban 150mg modified-release tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 375mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane LS 3.75mg tablets (Sanofi) and Zopiclone 3.75mg tablets (Accord Healthcare Ltd).

Stability Notes

Unsuitable for MCA as dispersible tablets.

Provenance

This compatibility recommendation is derived from Lamictal 5mg dispersible tablets (GlaxoSmithKline UK Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Eldepryl 5mg tablets (Orion Pharma (UK) Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Eldepryl 10mg tablets (Orion Pharma (UK) Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.